UPDATE 1-FDA declines to approve Alimera's eye drug, shares tank
Dec 23 (Reuters) - The U.S. Food and Drug Administration declined to approve Alimera Sciences Inc's experimental drug to treat retinal swelling in its current form, sending the biopharmaceutical...
Inga kommentarer:
Skicka en kommentar